Home › Funds › Eukles Asset Management › RMD

Eukles Asset Management position in RMD

RESMED INC · Health Care

Eukles Asset Management reported holding 18,669 shares of RMD (RESMED INC) in its Q3 2026 13F filing — a position valued at US$4.1M, representing 1.65% of its reported portfolio and ranking #19 among its reported holdings. Eukles Asset Management has disclosed RMD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)18.67K sh
Reported value held$4.13M
Portfolio Weight1.65%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Eukles Asset Management's RMD position evolved

Eukles Asset Management first disclosed a stake in RMD in Q3 2023 at 22,363 shares (US$3.3M). The position peaked in Q3 2025 at 22,865 shares, worth US$6.3M. Across 13 filings, Eukles Asset Management increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 18,669 shares valued at US$4.1M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 22.36K $3.31M New
Q4 2023 22.37K $3.85M Hold
Q1 2024 23.27K $4.61M Add
Q2 2024 23.36K $4.47M Hold
Q3 2024 23.27K $5.68M Hold
Q4 2024 22.33K $5.11M Reduce
Q1 2025 22.89K $5.13M Add
Q2 2025 22.94K $5.92M Hold
Q3 2025 22.86K $6.26M Hold
Q4 2025 22.74K $5.48M Reduce
Q1 2026 19.41K $4.36M Reduce
Q2 2026 18.76K $3.66M Reduce
Q3 2026 18.67K $4.13M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RMD and 13F data

RMD (RESMED INC) is a Health Care company. 31 other funds we track also report a position in RMD — the largest reported positions include Ilex Capital Partners (UK) LLP (US$163.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RMD

All RMD fund holders →

FAQ

How long has Eukles Asset Management held RMD?

Eukles Asset Management has disclosed RMD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Eukles Asset Management's current position in RMD?

As of Q3 2026, Eukles Asset Management holds 18.67K shares of RMD (RESMED INC), valued at $4.13M, representing 1.65% of its reported portfolio and ranking #19.

Has Eukles Asset Management been buying or selling RMD?

In the latest 13F filing (Q3 2026), Eukles Asset Management held unchanged its position in RMD. The position peaked in Q3 2025 at 22.86K shares.

Which other funds hold RMD?

Other major institutional holders of RMD include Ilex Capital Partners (UK) LLP, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.